Chronic kidney disease (CKD) patients have a shorter life expectancy than healthy individuals, from the premature development of cardiovascular disease due to traditional and non-traditional risk factors. It is therefore pertinent that management of CKD be aimed at modifying these cardiovascular disease risk factors. Exercise therapy, in particular aerobic exercise, in the end stage kidney disease population has been shown to decrease cardiovascular disease risk factors and subsequent cardiovascular disease. However, Section 2 contains the second trial that investigated the feasibility and efficacy of a 12 week HIIT program in CKD patients. Recruitment for the HIIT study was through participants who had completed the LM3 study.Chapter 1 provides an introduction to the studies, including the aims of the thesis. Topics reviewed include; pathophysiology of CKD, exercise capacity, autonomic dysfunction, haemoglobin, muscle atrophy, oxidative stress, inflammation, blood lipids and HIIT. Section 1 starts with the detailed methods of the LM3 study (Chapter 2). Further methods applicable to specific studies are reported in the relevant chapter.Chapter 3 investigates the determinants of reduced muscle strength at baseline through a cross-sectional analysis of the LM3 study. This study identified the association of oxidative 3 stress with low muscle strength and reduced lean mass. The relationship was independent of known influences on muscle mass and strength.The feasibility and determinants of the LI group participating in higher intensity exercise training in the first 12 months of the LM3 study was investigated in Chapter 4. The findings identified that higher intensity exercise training was indeed feasible in the CKD cohort, with the number of participants reporting higher intensity exercise increasing from 20% to 43%.Reported higher intensity exercise during the LI was also associated with the greatest exercise capacity at 12 months. Furthermore, the analysis identified haemoglobin to be the greatest predictor of individuals reporting higher intensity exercise.Chapter 5 investigates the agreement between creatinine and cystatin-C estimated glomerular filtration rate (eGFR) measurements in patients completing 12 months of the LM3 study. This chapter explores whether discrepancies in the CKD Epidemiology Collaboration (CKD-EPI)cystatin-C, CKD-EPIcreatinine and modification of diet in renal disease (MDRD) eGFR equations occur after an exercise intervention. It was identified that cystatin-C based eGFR measurements were considerably lower than creatinine based eGFR measurements. Despite this discrepancy at baseline, the agreement between the different GFR estimates did not change after exercise training.Chapter 6 contains the main study from LM3, which investigates the changes in cardiorespiratory fitness, exercise capacity, functional capacity, blood biochemistry, anthropometry measures and other cardiovascular disease risk factors after 3 years of LI compared to the control group. The primary finding from this...